サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：調剤薬局の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
市場調査レポート
商品コード
1342731

調剤薬局の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

Global Compounding Pharmacies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 232 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
調剤薬局の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 232 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

調剤薬局市場の世界需要は、調査期間2023年～2030年のCAGR 8.74%で、2022年の144億4,000万米ドルから2030年にはほぼ282億3,000万米ドルの市場規模に達すると推定されます。

調剤薬局は、カスタマイズされた薬を受け取るための安全で信頼できる方法です。調剤薬局は特定のタイプの薬局です。調剤薬局は、市販の医薬品では対応できないニーズを持つ特定の患者のために、医師が処方する医薬品を製造します。調剤薬局は、患者の好みや制限に基づいてカスタマイズされた剤形を作ることができます。調剤薬局は、医師の処方箋によって入手した薬のみを発行します。調剤薬局は、製品が調剤基準に沿って調合されていることを消費者に保証するために、特別な品質評価を受けます。

市場力学

がんなどの慢性疾患は、調剤薬局への資金提供の増加とともに一般的になりつつあり、予測期間中に市場を押し上げると思われます。また、薬剤の不足は、地域全体の調剤薬局の成長の強力な理由となっています。さらに、調合薬の利点に対する認識が高まることで、そのような個別化された薬の使用が増え、市場の成長につながります。様々な疾患を効果的に治療するための製剤を革新しカスタマイズするための研究開発に対する主要市場プレイヤーの投資が急増していることも、調剤薬局市場の成長を後押しすると予想されます。しかし、複雑な製剤の製造に対する規制の強化は、市場の成長を阻害する可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは調剤薬局の世界市場における各セグメントを包括的に評価することもできます。調剤薬局業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける調剤薬局市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 調剤薬局- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 世界の調剤薬局市場分析：治療領域別

  • 治療領域別概要
  • 実績データと予測データ
  • 治療領域別分析
  • 皮膚科領域
  • 疼痛管理
  • 専門医薬品
  • 栄養補助食品
  • ホルモン補充剤
  • その他

第7章 世界の調剤薬局市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 経口剤（固形剤、液体剤）
  • 局所用（クリーム、ゲル、軟膏、貼り薬、その他
  • 直腸剤（浣腸、坐剤、その他）
  • 非経口剤（LVP、SVP）
  • 眼科用剤
  • 経鼻
  • 耳鼻咽喉科

第8章 調剤薬局の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 小児
  • 高齢者
  • 成人
  • 獣医

第9章 調剤薬局の世界市場分析：調剤タイプ別

  • 配合タイプ別概要
  • 実績データと予測データ
  • 配合タイプ別分析
  • 医薬品用量変更（PDA）
  • 医薬品成分変更（PIA）
  • 現在入手不可能な医薬品製造（CUPM）
  • その他

第10章 世界の調剤薬局市場分析：無菌性別

  • 無菌性別概要
  • 実績データと予測データ
  • 無菌性別分析
  • 非滅菌
  • 滅菌

第11章 世界の調剤薬局市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 調剤薬局
  • 病院薬局
  • その他

第12章 世界の調剤薬局市場売上分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第13章 調剤薬局企業の競合情勢

  • 調剤薬局市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第14章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Fagron
  • B. Braun
  • Nephron Pharmaceuticals Corporation
  • Fresenius Kabi
  • Athenex Pharma Solutions（Athenex Inc.）
  • Dougherty's Pharmacy Inc.
  • Clinigen Group PLC
  • Pencol Compounding Pharmacy
  • Lorraine's Pharmacy
  • McGuff Company Inc.（McGuff Compounding Pharmacy Services）
  • Institutional Pharmacy Solutions
  • Rx3 Compounding Pharmacy
  • Wedgewood Village Pharmacy Inc.
  • Triangle Compounding Pharmacies
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Compounding Pharmacies Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Compounding Pharmacies Report
  • Market Research Process
  • Market Research Methodology
  • Global Compounding Pharmacies Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Compounding Type
  • Market Attractiveness Analysis by Sterility
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Global Market Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219448

The global demand for Compounding Pharmacies Market is presumed to reach the market size of nearly USD 28.23 BN by 2030 from USD 14.44 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

Compounding pharmacies are a safe and reliable way to receive customized medications. Compounding pharmacies are specific types of pharmacies. Compounding pharmacies are to make drugs prescribed by doctors for specific patients with needs that commercially available drugs cannot meet. Compounding pharmacies can create customized dosage forms based on patient preferences and restrictions. Compounding pharmacies will only issue those medications obtained via a doctor's prescription. Compounding pharmacies undergo an extra quality assessment to assure consumers that the product has been compounded to compounding standards.

MARKET DYNAMICS

The chronic diseases such as cancer are becoming more common along with increasing funding for compounding pharmacies will boost the market over the forecast period. Also, the shortage of drugs is a strong reason for the growth of compounding pharmacies across the region. Moreover, the growing awareness about the benefits of compounded medications will lead to higher use of such personalized medications and result in market growth. The surging investments by the key market players in research and development to innovate and customize the formulations to effectively treat various diseases are expected to boost the growth of the compounding pharmacies market. However, increased restrictions on manufacturing complex formulations may hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounding pharmacies. The growth and trends of compounding pharmacies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the compounding pharmacies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutic Area

  • Dermatology
  • Pain Management
  • Specialty Drugs
  • Nutritional Supplements
  • Hormone Replacement
  • Others

By Product

  • Oral (Solid Preparations, Liquid Preparations)
  • Topical (Creams, Gels, Ointments, Pastes, Others
  • Rectal (Enema, Suppositories, Others)
  • Parenteral (LVP, SVP)
  • Ophthalmic
  • Nasal
  • Otic

By Application

  • Pediatric
  • Geriatric
  • Adult
  • Veterinary

By Compounding Type

  • Pharmaceutical Dosage Alteration (PDA)
  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

By Sterility

  • Non-Sterile
  • Sterile

By Distribution Channel

  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Compounding Pharmacies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounding pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty's Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc. and Triangle Compounding Pharmacies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . COMPOUNDING PHARMACIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Compounding Type
    • 3.7.5 Market Attractiveness Analysis By Sterility
    • 3.7.6 Market Attractiveness Analysis By Distribution Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1 Overview by Therapeutic Area
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapeutic Area
  • 6.4 Dermatology Historic and Forecast Sales by Regions
  • 6.5 Pain Management Historic and Forecast Sales by Regions
  • 6.6 Specialty Drugs Historic and Forecast Sales by Regions
  • 6.7 Nutritional Supplements Historic and Forecast Sales by Regions
  • 6.8 Hormone Replacement Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Oral (Solid Preparations, Liquid Preparations) Historic and Forecast Sales by Regions
  • 7.5 Topical (Creams, Gels, Ointments, Pastes, Others Historic and Forecast Sales by Regions
  • 7.6 Rectal (Enema, Suppositories, Others) Historic and Forecast Sales by Regions
  • 7.7 Parenteral (LVP, SVP) Historic and Forecast Sales by Regions
  • 7.8 Ophthalmic Historic and Forecast Sales by Regions
  • 7.9 Nasal Historic and Forecast Sales by Regions
  • 7.10. Otic Historic and Forecast Sales by Regions

8 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Pediatric Historic and Forecast Sales by Regions
  • 8.5 Geriatric Historic and Forecast Sales by Regions
  • 8.6 Adult Historic and Forecast Sales by Regions
  • 8.7 Veterinary Historic and Forecast Sales by Regions

9 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY COMPOUNDING TYPE

  • 9.1 Overview by Compounding Type
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Compounding Type
  • 9.4 Pharmaceutical Dosage Alteration (PDA) Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical Ingredient Alteration (PIA) Historic and Forecast Sales by Regions
  • 9.6 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY STERILITY

  • 10.1 Overview by Sterility
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Sterility
  • 10.4 Non-sterile Historic and Forecast Sales by Regions
  • 10.5 Sterile Historic and Forecast Sales by Regions

11 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 11.1 Overview by Distribution Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Distribution Channel
  • 11.4 Compounding Pharmacy Historic and Forecast Sales by Regions
  • 11.5 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 11.6 Others Historic and Forecast Sales by Regions

12 . GLOBAL COMPOUNDING PHARMACIES MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE COMPOUNDING PHARMACIES COMPANIES

  • 13.1. Compounding Pharmacies Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF COMPOUNDING PHARMACIES INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Fagron
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. B. Braun
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Nephron Pharmaceuticals Corporation
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Fresenius Kabi
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Athenex Pharma Solutions (Athenex Inc.)
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Dougherty's Pharmacy Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Clinigen Group PLC
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Pencol Compounding Pharmacy
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. Lorraine's Pharmacy
    • 14.11.1. Company Overview
    • 14.11.2. Company Revenue
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. McGuff Company Inc. (McGuff Compounding Pharmacy Services)
    • 14.12.1. Company Overview
    • 14.12.2. Company Revenue
    • 14.12.3. Products
    • 14.12.4. Recent Developments
  • 14.13. Institutional Pharmacy Solutions
    • 14.13.1. Company Overview
    • 14.13.2. Company Revenue
    • 14.13.3. Products
    • 14.13.4. Recent Developments
  • 14.14. Rx3 Compounding Pharmacy
    • 14.14.1. Company Overview
    • 14.14.2. Company Revenue
    • 14.14.3. Products
    • 14.14.4. Recent Developments
  • 14.15. Wedgewood Village Pharmacy Inc.
    • 14.15.1. Company Overview
    • 14.15.2. Company Revenue
    • 14.15.3. Products
    • 14.15.4. Recent Developments
  • 14.16. Triangle Compounding Pharmacies
    • 14.16.1. Company Overview
    • 14.16.2. Company Revenue
    • 14.16.3. Products
    • 14.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies